Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary
- PMID: 15325435
- DOI: 10.1016/j.ijantimicag.2004.01.009
Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary
Abstract
A total of 341 clinical isolates of Streptococcus pyogenes from Vienna, Austria and three Hungarian cities were tested for susceptibility to four macrolides and 12 other antibiotics. All isolates were fully susceptible to penicillin and the other beta-lactams tested. A high level of tetracycline resistance was found in Austria (26.7%) and in Hungary (30.5%). The rate of resistance to erythromycin, clarithromycin and azithromycin was 4.7% in Vienna and 3.7% in the Hungarian communities. In both countries, the MIC(90) values of erythromycin and clarithromycin were 0.12 mg/L and the MIC(90) of josamycin was 0.5mg/L. The M phenotype of resistance conferred by the mefA genes was predominant (n = 9) among the macrolide-resistant isolates (n = 14).
Similar articles
-
High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.Pediatr Pulmonol. 2009 May;44(5):436-41. doi: 10.1002/ppul.20976. Pediatr Pulmonol. 2009. PMID: 19360846
-
Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.APMIS. 2010 May;118(5):366-70. doi: 10.1111/j.1600-0463.2010.02607.x. APMIS. 2010. PMID: 20477812
-
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.Diagn Microbiol Infect Dis. 2009 May;64(1):52-6. doi: 10.1016/j.diagmicrobio.2008.12.018. Epub 2009 Feb 18. Diagn Microbiol Infect Dis. 2009. PMID: 19232860
-
[Resistance to macrolides in Streptococcus pyogenes].Rev Esp Quimioter. 1998 Sep;11(3):196-204. Rev Esp Quimioter. 1998. PMID: 9795305 Review. Spanish. No abstract available.
-
Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.Pediatr Infect Dis J. 2004 Feb;23(2 Suppl):S129-34. doi: 10.1097/01.inf.0000112527.33870.0d. Pediatr Infect Dis J. 2004. PMID: 14770076 Review.
Cited by
-
Heme-bound SiaA from Streptococcus pyogenes: Effects of mutations and oxidation state on protein stability.J Inorg Biochem. 2016 May;158:99-109. doi: 10.1016/j.jinorgbio.2015.10.016. Epub 2015 Nov 14. J Inorg Biochem. 2016. PMID: 26746808 Free PMC article.
-
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.Infection. 2009 Aug;37(4):353-7. doi: 10.1007/s15010-008-8023-1. Epub 2008 Dec 5. Infection. 2009. PMID: 19137242
-
Anti-Bacterial Activity of Phenolic Compounds against Streptococcus pyogenes.Medicines (Basel). 2017 May 1;4(2):25. doi: 10.3390/medicines4020025. Medicines (Basel). 2017. PMID: 28930240 Free PMC article.
-
Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.Microb Drug Resist. 2010 Dec;16(4):279-84. doi: 10.1089/mdr.2010.0021. Epub 2010 Jul 12. Microb Drug Resist. 2010. PMID: 20624096 Free PMC article.
-
Molecular characterization and evaluation of the emerging antibiotic-resistant Streptococcus pyogenes from eastern India.BMC Infect Dis. 2016 Dec 12;16(1):753. doi: 10.1186/s12879-016-2079-9. BMC Infect Dis. 2016. PMID: 27955635 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical